Maria Bikuna Izagirre; Colleen Mathieu; Morgan Yeh; Amelia Duguay; Renato Castillo; Sotcheadt Sim; Eric Quenneville; Martin Garon
Osteoarthritis and Cartilage. 2026;34(Supplement):S342. OARSI abstract 494.
https://doi.org/10.1016/j.joca.2026.01.491
0 citations · 0 en 2025–2026
Les titres, résumés et légendes des publications sont présentés en anglais.
Osteoarthritis (OA) is a chronic joint disease arising from untreated cartilage lesions and is characterized by a deterioration of cartilage’s mechanical properties and biochemical composition [1]. Additionally, electromechanical properties also decline with cartilage degradation, which can be measured by the quantitative parameter (QP), a marker of cartilage’s quality and OA severity [2]. Advances in disease-modifying therapies have been limited by the lack of reliable preclinical models that faithfully replicate human OA. Large animal osteochondral plugs provide a reproducible ex vivo platform, yet validation against human disease remains necessary. Equine stifle joints are a suitable source due to their human-like cartilage thickness and preserved bone-cartilage interface [3]. This study compares equine and human plugs across OA stages to evaluate the suitability of equine tissue as an in vitro translational OA model and to establish a quantitative reference database of OA-associated degeneration.
Utilisation des équipements
L’Arthro-BST sert à évaluer la qualité électromécanique du cartilage au moyen du paramètre quantitatif (QP).
Matériaux (1)

